Recent progress in visfatin

陶弢,刘伟

2007-01-01

Abstract:内脂素是一种主要由内脏脂肪分泌的细胞因子,通过与胰岛素受体结合发挥类胰岛素样的降血糖作用,并促进脂肪组织的分化与合成.有研究认为内脂素由于结构缺陷可能并非真正具类胰岛素样作用.尽管如此,内脂素仍为肥胖和糖尿病治疗提供可能靶点。

What problem does this paper attempt to address?

Visfatin: A New Adipocytokine

张春梅,郭锡熔

DOI: https://doi.org/10.3760/cma.j.issn.1673-4408.2007.02.013

2007-01-01

International Journal of Pediatrics

Abstract:Visfatin是新近发现的由内脏脂肪组织分泌的一种脂肪细胞因子.它能够通过与胰岛素受体结合激活胰岛素信号通路降低血糖,并具有促进脂肪细胞分化、脂质合成与积聚等生物学活性.深入探讨其作用机制可能为进一步认识代谢性疾病的发病机制及临床防治提供一个新的思路.目前有关visfafin的研究尚存在很大争议,该文就近几年的研究进展及相关争议进行简单综述。
Visfatin, a Newly Identified Adipokine

Hua ZHOU,Guo-Ping CAI

DOI: https://doi.org/10.3969/j.issn.1000-1336.2006.03.006

2006-01-01

Abstract:visfatin是新近发现的主要由人和小鼠内脏脂肪组织分泌的一种脂肪细胞因子,其结构与pre-B细胞集落增强因子相似。它能够发挥类似胰岛素的作用,与Ⅱ型糖尿病相关联,降低血糖,促进糖摄取,可结合并活化胰岛素受体,激活胰岛素信号通路。Visfatin与肥胖密切相关并能够促进脂肪细胞的分化,还能促进血管平滑肌细胞成熟。Visfatin的表达受炎症反应因子和多种激素的调节。Visfatin可能是联系机体糖脂代谢的重要分子,它的发现可为揭示糖尿病与肥胖的发生发展机制提供新的研究思路,为代谢综合征的治疗提供新方案。
Research Progress on the Relationship between High-fat Diet, Intestinal Flora, Bile Acid Metabolism and Insulin Resistance

Zhong Hao,Wang Jian,Feng Fengqin,Guan Rongfa,Yang Mengyu

DOI: https://doi.org/10.16429/j.1009-7848.2023.03.036

2023-01-01

Abstract:In recent years, the incidence rate of Type 2 diabetes mellitus（T2DM） has been increasing. In 2019, there were about 417 million T2DM patients worldwide and 104 million in China, which has been a threat to human health and quality of life. The main symptom of T2DM is insulin resistance（IR） that the body cannot respond normally to insulin. Excessive intake of high fat diet（HFD） is the major incentive of IR. Many studies have proved that HFD can lead to intestinal micro-ecological imbalance, which in turn induces the IR of metabolic tissues. Researches have shown that the intestinal micro-ecology mainly controls the body’s glucose and lipid metabolism by regulating the body’s energy metabolism and inflammation. Further research suggests that bile acid metabolism disorder caused by intestinal micro-ecological imbalance is also another important cause of insulin resistance in the body. Therefore, this article will review the interactions among high-fat diet, intestinal flora and insulin resistance from different aspects, such as high-fat diet and insulin resistance, intestinal flora and insulin resistance, and the ’gut microbiota-bile acid-insulin resistance’. Although there is no evidence to confirm the causal relationship of ’high-fat diet-intestinal flora-bile acid’ in the occurrence and development of insulin resistance, but the mutual regulations between intestinal flora and bile acid metabolism provide enlightenment for insulin resistance, prevention and treatment of T2DM.
Recent progress of visfatin

Shuang ZHANG,Cheng-jiang LI

DOI: https://doi.org/10.3760/cma.j.issn.1673-4157.2009.s1.008

2009-01-01

International Journal of Endocrinology and Metabolism

Abstract:Visfatin, a novel adipocytokine, is mainly released from visceral adipose tissue. Visfatin can promote fat accumulation, have insulin-like role, and play a role in promoting the expression of inflamma-tory cytokines and induction of angiogenesis. A number of studies show that visfatin is higher in patients with metabolic disorders, such as obesity, diabetes, metabolic syndrome and so on, as well as in patients with cardi-ovascular disease such as coronary heart disease and so on. The studies also found that visfatin is closely re-lated to polycystic ovarian syndrome, nonalcoholic fatty liver disease. Current studies have shown that visfatin is the extracellular form of nicotinamide phosphofibosyl transferase (Nampt). The role of Nampt might be a-ble to fully explain the complex mechanism of visfatin. This idea provides a new therapeutic direction for obe-sity, diabetes, cardiovascular diseases and so on.
Progress of Adipocytokin-visfatin

刘蓉,朱剑,刘超

DOI: https://doi.org/10.3969/j.issn.1006-2084.2008.11.008

2008-01-01

Abstract:Visfatin is a newly identified adipocytokin.Its cDNA sequencing of reverse transcription is the same as the structure of gene encoding pre-B cell colony enhancing factor.It is mainly secreted by visceral fatty tissue.It can bind with insulin receptors and then activate them,can produce insulin-like effect,can promote the differentiation of lipocytes and has some association with type 2 diabetes.Further study showed that it also related to the mature of vascular smooth muscle cells and inflammation.The finding of Vistatin provides new contents to study the pathegensis of obesity and diabetes,what is more,it also will provide new therapeutic target for the therapy of diabetes.
Recent Advances on the Relationship Between Visfatin and Type 2 Diabetes Mellitus

赵暕,苏运超,吴立玲

2009-01-01

Abstract:Visfatin is a newly discovered adipocytokine which is synthesized mainly by visceral fat. Visfatin can mimic in- sulin-like effect, reduce blood glucose, facilitate accumulation and synthesis of adipose tissue. Besides, visfatin not only can regulate the maturation of vascular smooth muscle and effect islet cells secreting insulin, but also can regulate. the inflammatory reaction and immune response Along with the development of the studies, structure, distribution, modulations of expression and biofunctions of visfatin have been better understood now. Type 2 diabetes mellitus is a metabolic disease characterized by insulin resistance and glucose metabolic dis- turbance. Visfatin plays an important role in the pathogenesis of type 2 diabetes mellitus, and especially correlates with obesity, insulin resistance and insulin secretion reduction. The further study of visfatin biological and pathophysiological effects may contribute to the knowledge of the therapy and the prevention of type 2 diabetes mellitus.
Research progress in relationship between Visfatin and obesity and diabetes mellitus

YANG Jie-jin,LIU Wei

DOI: https://doi.org/10.3969/j.issn.1674-8115.2008.09.034

2008-01-01

Abstract:Visfatin is a novel identified adipocytokine which was named as pre-B cell colony-enhancing factor(PEBF) before.Many studies have revealed its insulin-mimetic action.Visfatin can promote the differentiation of adipocytes,suppress the glucose release of hepatocytes,and accelerate the maturation of smooth muscle cells.Visfatin is related with the metabolism of glucose and lipid.Further studies on Visfatin may facilitate the treatment of diabetes mellitus and metabolic syndrome.
Advances in Research on the Role of Visfatin in Glucose Metabolism and Vascular Disease

Liansheng Wang

2011-01-01

Abstract:The adipocytokines secreted by adipose tissue have different effects on lipid metabolism,metabolic syndrome,and cardiovascular risk.Visfatin,recently identified as a novel adipocytokine,has potentially important effects on glucose metabolism and atherosclerosis.Further research of vistafin may contribute to improving identification of high risk individuals with diabetes and cardiovascular disease and a better understanding of the complex inter-correlation between adiposity,glucose metabolism and cardiovascular disease.
The expressions and significant of visfatin, resistin and adiponectin in diabetic rats adipose tissue

LIAO Xin,TIAN Hao-ming,GAO Lin,HUANG Qi,YANG Yan,CHEN Ling

2013-01-01

Abstract:【Objective】To explore the mRNA expression changes and significant of visfatin,resistin and adiponectin in diabetic rats adipose tissue with short-term insulin treatment.【Methods】The DM rats were divided into 3 groups(the strict control group,the non-strict control group and the uncontrolled group) according to the target levels of blood glucose which were controlled by protamine zinc insulin,the visfatin,resistin and adiponectin mRNA expressions in visceral adipose in different blood glucose of diabetic rats were examined.The changes of serum visfatin,FFA,TG,TC levels of different blood glucose diabetic rats were observed.【Results】The levels of serum FFA,TG were decreased significantly in the group of strict control blood glucose compared with the group of uncontrolled blood glucose(P <0.05),yet the levels of TC increased significantly(P <0.05).The expressions of visfatin,resistin in diabetic rats adipose tissue in the group of uncontrolled blood glucose were significant increased compared with normal control group,the expression of adiponectin was significant decreased(P <0.05,respectively).The expression of visfatin was significant decreased(P <0.05),resistin was decreased;adiponectin was increased following with the decreasing of blood glucose.Visfatin was positive correlation with resistin in diabetic rat adipose tissue(r =0.689,P <0.05).【Conclusion】Visfatin,resistin and adiponectin maybe play roles in the metabolism of glycolipids in diabetic rats.
Glucagon like peptide-1 increases visfatin expression in 3T3-L1 adipocytes via PKA pathway

LIU Rui,PENG Yong-de,DONG Wei-ping,ZHANG Ai-fang,WANG Yi-fei,DING Xiao-ying

DOI: https://doi.org/10.3760/cma.j.issn.1000-6699.2013.11.015

2013-01-01

Abstract:Objective To test whether glucagon like peptide-1 (GLP-1) would regulate the expression of visfatin in adipocytes,and to explore the mechanism of this effect.Methods Fully differentiated 3T3-L1 adipocytes were treated with GLP-1.Total RNA was extracted for analyzing the level of visfatin mRNA by quantitative RT-PCR.The media were collected for measuring the level of visfatin protein by enzyme linked immuno-assay (ELISA).In order to test the involvement of PKA pathway,the adipocytes were pretreated with a specific pharmacological PKA inhibitor H89 for 30 min before GLP-1 was added.Results GLP-1 increased visfatin expression in a time-and dose-dependent manner.The level of visfatin significantly increased at the concentration of 10 10 mol/L GLP-1 (P＜0.05),and reached the peak at 10-9 mol/L (P＜0.01).After incubation for 18 hours,GLP-1 dominantly increased the level of visfatin (P＜0.05).Inhibition of PKA pathway by H89 partially blocked the effect of GLP-1 on visfatin expression.Conclusions GLP-1 may enhance the expression of visfatin in 3T3-L1 adipocyte via the PKA pathway,which might contribute to the improvement in glucose homeostasis.
Progress in relationship between resistin and obesity, insulin resistance as well as cardiovascular disease

刘峰,郭锡熔,陈荣华

DOI: https://doi.org/10.3760/cma.j.issn.1673-4408.2008.01.025

2008-01-01

International Journal of Pediatrics

Abstract:Resistin(抵抗素)是抵抗素样分子家族成员之一,是由脂肪细胞分泌的、富含半胱氨酸的细胞因子.啮齿类动物体内resistin的主要作用是诱导胰岛素抵抗:重组resistin作用于脂肪细胞和骨骼肌细胞能诱导细胞水平胰岛素刺激的葡萄糖摄取;Resistin转基因小鼠表现出了整体水平的胰岛素抵抗现象.现发现resisfin与机体多种疾病相关,如肥胖、胰岛素抵抗、2型糖尿病、心血管疾病等.该文主要对resisin在相关疾病中的作用及其机制作一综述。
Glucagon-like Peptide-1 Upregulates Visfatin Expression in 3T3-L1 Adipocytes

R. Liu,X. Ding,Y. Wang,M. Wang,Y. Peng

DOI: https://doi.org/10.1055/s-0033-1343472

2013-01-01

Hormone and Metabolic Research

Abstract:Abstract The incretin hormone glucagon-like peptide-1 (GLP-1) exerts important functions in controlling glucose homeostasis. Many studies have revealed molecular targets of GLP-1, but its influence on adipokines has not been determined. Visfatin, a recently discovered adipokine, has been shown to attenuate insulin resistance by binding to insulin receptor. Our study shows that GLP-1 induced secretion of visfatin into the culture medium of 3T3-L1 adipocytes due to increased visfatin mRNA expression. Furthermore, the effect of GLP-1 on visfatin was dose- and time-dependent. H89, a protein kinase A inhibitor, prevented the induction of visfatin expression by GLP-1. Moreover, inhibition of NF-κB by PDTC reduced the basal visfatin release while having no effect on the transcription regulation by GLP-1. In addition, GLP-1 alleviated the decrease of visfatin mRNA expression under endoplasmic reticulum stress induced by thapsigargin. Taken together, our study suggests that GLP-1 promotes the novel insulin-mimetic adipocytokine visfatin expression via the PKA pathway and might influence glucose metabolism.
Effect of Exercise on Expression of Visfatin of Visceral Fat in High-Fat-diet-fed Rats

SHANG Jing,CHEN Lu-lu,SUN Hui,XIAO Fang-xi,SHU Yan-wen

DOI: https://doi.org/10.3969/j.issn.1005-8982.2008.05.010

2008-01-01

Abstract:[Objective] To investigate the effect of exercise on rats fed with high fat and explore the relationship between visfatin and visceral obesity, metabolic dysregulation. [Methods] 30 healthy Wistar rats were randomly assigned to normal-fat-diet group (ND) and high-fit-diet group (HD). 18 weeks later, half rats of the HD group were randomly assigned to high-diet swimming grou(HS). The HS group was arranged to swim for 6 weeks. Then body weight and body length of rats, blood lipid, fasting blood glucose and insulin were measured. Half rats of each group received insulin sensitivity with Hyperinsulinemic-euglycemic clamp estimation . The visfatin gene expression was measured by RT-PCR. [Results] In the 18th week, the Lee's index, fasting blood glucose and insulin, blood lipid of HD group were significantly higher than those of ND group; In the 24th week, metabolic indexes of HS group such as hyperlipidemia, insulin sensitivity were markedly improved and the visceral fat deposit was significantly reduced comparing with HD group(P 0.01). Meanwhile, the gene expression of visfatin in perirenal fat in HS rats declined correspondingly compared with HD group. [Conclusion] There is close relationship between the expression of visfatin and the visceral fat deposit, metabolic dysregulation, Weight lose by exercise is partly due to the inhibition of visfatin in visceral fat .
Plasma Visfatin Levels in Patients with Newly Diagnosed and Untreated Type 2 Diabetes Mellitus and Impaired Glucose Tolerance

刘蓉,朱剑,王茜,沈备,刘翠萍,徐宽枫,茅晓东,刘超

DOI: https://doi.org/10.3969/j.issn.1005-2194.2007.16.016

2007-01-01

Abstract:Objective To investigate the plasma visfatin levels and explore the relationship between visfatin and anthropometric parameters,glucose,lipid profile,insulin sensitivity index and insulin secretion index in the subjects with different glucose tolerances.Methods Fifty-three patients with newly diagonosed type 2 diabetes(T2DM),7 subjects with impaired glucose tolerance(IGT)and 35 healthy controls were enrolled.Visfatin levels were measured along with the BMI,blood pressure,lipids,glucose,insulin and HOMA-IR indexes.Results Plasma visfatin levels were elevated in patients with newly diagnosed T2DM compared with IGT group or controls.There was no significant difference in the visfatin levels between IGT group and healthy controls.Plasma visfatin level was positively correlated with glucose levels and HOMA-IR,and negatively correlated with insulin secretion index(HOMA-B).Multiple regression analysis showed that postprandial plasma glucose was independent related factor influencing plasma visfatin levels.In T2DM group,plasma visfatin concentration was positively correlated with HbA1c level.Conclusion The increased plasma visfatin concentration in newly diagnosed and untreated type 2 diabetes mellitus represents a compensatory mechanism aimed at ameliorating the functional consequences of insulin deficiency.
Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions

Ernest Adeghate

DOI: https://doi.org/10.2174/092986708785133004

Abstract:Visfatin is a newly discovered adipocyte hormone with a direct relationship between plasma visfatin level and type 2 diabetes mellitus. Visfatin binds to the insulin receptor at a site distinct from that of insulin and causes hypoglycaemia by reducing glucose release from liver cells and stimulating glucose utilization in adipocytes and myocytes. Visfatin is upregulated by hypoxia, inflammation and hyperglycaemia and downregulated by insulin, somatostatin and statins. This hormone is found in the cytoplasm as well as the nucleus of cells and has been identified in many tissues and organs including the brain, kidney, lung, spleen and testis but preferentially expressed in visceral adipose tissue and upregulated in some animal models of obesity. Visceral adipose tissue is regarded to be more pernicious than subcutaneous adipose tissue. Visfatin is an endocrine, autocrine as well as paracrine peptide with many functions including enhancement of cell proliferation, biosynthesis of nicotinamide mono- and dinucleotide and hypoglycaemic effect. Visfatin, also known as a pre-B cell colony-enhancing factor, consists of 491 amino acids (aa) in human, chimpanzee, cattle, pig, rat and mouse, 490 aa in rhesus monkey, 285 aa in sheep, 587 in opossum and 588 aa in canines. Visfatin gene is well preserved during evolution. For example, the canine visfatin protein sequence is 96% and 94% identical to human and rodent visfatin, respectively. Since evidence of a direct link between visfatin genotype and human type 2 diabetes mellitus is still weak, more molecular, physiological and clinical studies are needed to determine the role of visfatin in the etiology and pathogenesis of type 2 diabetes mellitus.
Pancreatic Β Cell Apoptosis Inhibited by Visfatin Via Mitochondrial Pathways

程群,彭永德,董维平,王煜非,吴景程,丁晓颖

2009-01-01

Abstract:Objective To investigate the effects of visfatin on palmitate-induced islet β cell apoptosis. Methods Mouse pancreatic cell line MIN6 was performed in vitro serial subcultivation,and subjected to experiment during exponential phase of growth.Cell viability of MIN6 was detected by MTT assay 24 to 72 h after induction by visfatin with different concentrations(0 to 10-7 mol/L).Cell apoptosis rate of MIN6 was examined by flow cytometry after induction by 0.5 mmol/L palmitate and/or 10-8 mol/L visfatin for 24 h,and expression of bcl-2,bax,cleaved caspase-3 and cytochrome C in endochylema was determined by Western blotting. Results Cell viability of MIN6 increased in a dose-dependent manner after treatment with visfatin for 24 to 48 h(P0.05).It was revealed by flow cytometry that palmitate-induced apoptosis significantly reduced by 10-8 mol/L visfatin(P0.05).It was demonstrated by Western blotting that 10-8 mol/L visfatin significantly inhibited the decreased expression of bcl-2 and increased expression of cleaved caspase-3 and cytochrome C induced by palmitate(P0.05). Conclusion Visfatin may promote proliferation of pancreatic β cells,and inhibit palmitate-induced islet β cell apoptosis via mitochondrial pathways.
Serum levels of the adipokine vaspin in relation to metabolic and renal parameters

周丽斌,陈名道

DOI: https://doi.org/10.3321/j.issn:1000-6699.2008.02.038

2008-01-01

Abstract:近来研究发现,脂肪细胞分泌的脂肪因子与代谢综合征各组分密切相关,其分泌异常可导致肥胖患者心血管疾病的风险增加.2005年Hida等首先在OLETF(Otsuka Long-Evans Tokushima Fatty)2型糖尿病肥胖大鼠的内脏脂肪组织中发现的vaspin是一种具有胰岛素增敏作用的脂肪因子,属于丝氨酸蛋白酶抑制剂超家族。
Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.

Pei Wang,Chong Bai,Quan-Yi Xu,Tian-Ying Xu,Ding-Feng Su,Jean Sassard,Chao-Yu Miao

DOI: https://doi.org/10.1111/j.1440-1681.2010.05402.x

2010-01-01

Clinical and Experimental Pharmacology and Physiology

Abstract:P>1. Visfatin (also known as nicotinamide phosphoribosyltransferase or Nampt) is a novel adipokine associated with metabolic abnormalities in obesity and diabetes. The aim of the present study was to determine whether visfatin levels in the circulation and visfatin expression in fat tissues are altered in Lyon hypertensive (LH) rats, a hypertensive strain with numerous metabolic abnormalities, and, if so, to explore the possible correlations between blood visfatin levels and the metabolic abnormalities in LH rats. 2. Male 18-20-week-old LH rats and their control, Lyon normotensive (LN) rats, were used. Blood pressure was recorded in conscious, unrestrained rats. Fat tissue weight was determined. Serum visfatin concentrations were determined by enzyme immunoassay, whereas visfatin expression in fat tissues was determined by western blotting. Relationships between two parameters were evaluated by linear regression analysis. 3. The LH rats had significantly higher bodyweight and fat tissue weight compared with LN rats. Serum lipid levels of total cholesterol (TC), high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C) and triglyceride (TG) were all significantly higher in LH rats than in LN rats. Moreover, serum visfatin levels were higher in LH rats than in LN rats and were positively correlated with bodyweight, fat tissue weight and serum lipid levels (i.e. TC, HDL-C, LDL-C, TG and the TG:HDL-C ratio). There were no significant differences in serum glucose and insulin concentrations, or in the whole-body insulin resistance index, between LN and LH rats, and serum visfatin levels were not correlated with any of these parameters. Visfatin expression in visceral fat tissue, but not in subcutaneous fat tissue, was markedly upregulated in LH compared with LN rats. 4. In conclusion, the results of the present study demonstrate that serum visfatin levels in LH rats are elevated and are associated with lipid metabolic abnormalities.
Recent advance of fatty acid synthetase inhibitor

王敏奇

DOI: https://doi.org/10.3969/j.issn.1004-3314.2005.03.008

2005-01-01

Abstract:The regulation of animal lipogenesis,the effect of fatty acid synthase inhibitor on food intake and its relation with NPY and leptin were studied.
Exercise and Visfatin

SONG Gang,ZENG Ling-jie,XIE Min-hao

DOI: https://doi.org/10.3969/j.issn.1002-9826.2008.05.026

2008-01-01

Abstract:This paper summarized the relation between exercise and visfatin,explained the gene,metabolism and signal transportation of visfatin.The result showed that the relational mechanism between visfatin and metabolism diseases is still unclear and exercise may regulate the expression of visfatin through cAMP and PPARs.

Recent progress in visfatin

Visfatin: A New Adipocytokine

Visfatin, a Newly Identified Adipokine

Research Progress on the Relationship between High-fat Diet, Intestinal Flora, Bile Acid Metabolism and Insulin Resistance

Recent progress of visfatin

Progress of Adipocytokin-visfatin

Recent Advances on the Relationship Between Visfatin and Type 2 Diabetes Mellitus

Research progress in relationship between Visfatin and obesity and diabetes mellitus

Advances in Research on the Role of Visfatin in Glucose Metabolism and Vascular Disease

The expressions and significant of visfatin, resistin and adiponectin in diabetic rats adipose tissue

Glucagon like peptide-1 increases visfatin expression in 3T3-L1 adipocytes via PKA pathway

Progress in relationship between resistin and obesity, insulin resistance as well as cardiovascular disease

Glucagon-like Peptide-1 Upregulates Visfatin Expression in 3T3-L1 Adipocytes

Effect of Exercise on Expression of Visfatin of Visceral Fat in High-Fat-diet-fed Rats

Plasma Visfatin Levels in Patients with Newly Diagnosed and Untreated Type 2 Diabetes Mellitus and Impaired Glucose Tolerance

Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions

Pancreatic Β Cell Apoptosis Inhibited by Visfatin Via Mitochondrial Pathways

Serum levels of the adipokine vaspin in relation to metabolic and renal parameters

Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.

Recent advance of fatty acid synthetase inhibitor

Exercise and Visfatin